Gene Editing – Medical Alley Association

Gene Editing

Up & Running with Wesley Wierson, Founder and CEO, LEAH Labs

Wesley Wierson is a passionate scientist and entrepreneur applying his expertise in gene-editing technology to solve consumer-level problems in society. He studied microbiology as an undergraduate, where he was first exposed to gene-editing technology through undergraduate research. As a Ph.D. student, he developed gene-editing technology that permits the integration of exogenous genes into the genome, thus […]

Leah Labs Equity Crowdfunding Campaign Nears Close, Over $350K Raised

ROCHESTER, MN, December 9th, 2020 – The innovative animal health biotechnology company, LEAH Labs, has raised over $359,000 on its Wefunder crowdfunding campaign. This brings their total financing to date to nearly $700,000. The Wefunder campaign is open through February 20th. More information can be found at www.wefunder.com/LEAH.  Equity crowdfunding is a new form of […]

Aldevron to Build 14-Acre Gene Therapy Manufacturing Campus

August ground breaking of second GMP manufacturing facility Expands GMP and GMP SourceTM plasmid capacity 10-fold Supports gene editing, gene therapy, and cell therapy applications Includes synthetic production of nucleic acids, vertical integration for clients FARGO, N.D. (June 3, 2019) – Aldevron, a leader in the production of plasmid DNA, proteins, mRNA and antibodies; announced […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER